Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-03

FDA Approved: ISOSULFAN BLUE — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Meitheal Pharmaceuticals' original application for Isosulfan Blue, a surgical dye used to identify sentinel lymph nodes during cancer staging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isosulfan blue (Isosulfan blue)

Snippet

ORIG AP for ISOSULFAN BLUE (ISOSULFAN BLUE)